title: Why is hypertension so frequently uncontrolled in secondary prevention?
abstract: OBJECTIVE
  To analyze blood pressure (BP) control in secondary prevention.
  
  
  METHODS
  Individual data of two cross-sectional studies on preventive cardiology (PRATIK and ESPOIR studies conducted, respectively, in general practice and with private cardiologists) were analyzed.
  
  
  METHODS
  Primary care.
  
  
  METHODS
  Patients both with treated hypertension and coronary disease.
  
  
  METHODS
  Risk factors, treatments, cardiovascular history and BP were recorded. Each population was divided in three groups: group I, no other risk factor; group II, one or two risk factors; group III, three or more risk factors or diabetes.
  
  
  RESULTS
  A total of 1423 and 2596 patients, respectively, recruited in general practice and by cardiologists were analyzed. Of these, 473 (33.24%) and 1060 (40.83%) patients, respectively, had controlled hypertension. Among uncontrolled hypertensives, more than 50% had borderline isolated systolic hypertension. Associated risk factors negatively affect hypertension control, which had been achieved in a lower percentage of patients in group III than in group I (general practice, 26.28 versus 42.20%; cardiological practice, 32.42 versus 56.13%). In general practice, the percentage of patients receiving beta-blockers was significantly lower in group III. Among individuals with uncontrolled hypertension, only 17.58 and 26.69% received at least three-drug treatment including diuretics in general and in cardiological practice, respectively.
  
  
  CONCLUSIONS
  The negative influence of associated risk factors and the under-use of combination therapy contribute to poor BP control. In addition the high frequency of borderline isolated systolic hypertension suggests that the prerequisite to improve hypertension control should be to convince practitioners of the beneficial effect of tight systolic BP control (below 140 mmHg) in secondary prevention.
authors.affiliation: Médecine et Hypertension Artérielle, CHU Toulouse, France. amar.j@chu-toulouse.fr
authors.forename: Jacques
authors.initials: J
authors.lastname: Amar
authors.forename: Bernard
authors.initials: B
authors.lastname: Chamontin
authors.forename: Nathalie
authors.initials: N
authors.lastname: Genes
authors.forename: Christelle
authors.initials: C
authors.lastname: Cantet
authors.forename: Michel
authors.initials: M
authors.lastname: Salvador
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Cambou
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D017211:Treatment Failure
chemical_list: D000959:Antihypertensive Agents